Eyenuk
Woodland Hills, US · Founded 2013 · Delaware corporation · 1 known investors
Eyenuk provides autonomous AI-based eye exams performed at the point of care to detect eye conditions including diabetic retinopathy (DR), age-related macular degeneration (AMD), and glaucomatous signs. Its technology holds regulatory clearances such as a Class IIb CE mark under EU MDR and maintains SOC 2 Type 2, HIPAA, and GDPR compliance.
Founders & leadership
Eyenuk was founded in 2013 by Kaushal Solanki.
KS
Kaushal SolankiFounder
GA
Gaurav AgarwalExecutive
Board
MD
Mads DallBoard director
ZA
Zina Affas BesseBoard director
ML
Marie-Louise LittleBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$33.9M disclosed across 5 rounds · 2016–2026
▶$5.6MraisedJun 2026 · 12 investors · Other Health CareRule 506(b)
▶$5.6MraisedJun 2026 · 12 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Gaurav AgarwalExecutive Officer, Director
- Mads DallDirector
- Zina Affas BesseDirector
- Marie-Louise LittleDirector
- Kaushal SolankiDirector
- Offering amount
- $5.6M
- Amount sold
- $5.6M
- First sale
- Apr 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$22.4MraisedAug 2022 · 27 investors · Other Health CareRule 506(b)
▶$22.4MraisedAug 2022 · 27 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Frank ChengExecutive Officer
- Zina Affas BesseDirector
- Kaushal SolankiExecutive Officer, Director
- Marie-Louise LittleDirector
- Manish PottiDirector
- Robert BinneyDirector
- Offering amount
- $26.9M
- Amount sold
- $22.4M
- First sale
- Aug 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3MraisedMay 2018 · 6 investors · Other Health CareRule 506(b)
▶$3MraisedMay 2018 · 6 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Martin CoyneDirector
- Kaushal SolankiExecutive Officer, Director
- Manish PottiDirector
- Offering amount
- $4M
- Amount sold
- $3M
- First sale
- Apr 2018
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
▶$1.4MraisedNov 2017 · 8 investors · Other Health CareRule 506(b)
▶$1.4MraisedNov 2017 · 8 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Manish PottiDirector
- Martin CoyneDirector
- Kaushal SolankiExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $1.4M
- First sale
- Oct 2017
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
▶$1.5MraisedJul 2016 · 7 investors · Other Health CareRule 506(b)
▶$1.5MraisedJul 2016 · 7 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Kaushal SolankiExecutive Officer, Director
- Offering amount
- $2.3M
- Amount sold
- $1.5M
- First sale
- Jul 2016
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 5
by search overlapAeyehealth46 shared keywordsAEYE Health makes AEYE-DS, an FDA-cleared autonomous AI system that screens for diabetic retinopathy using portable and tabletop retinal cameras, producing a diagnostic report in about a minute without physician interpretation. It is designed for primary care physicians to perform point-of-care screening and replace specialist referrals.
Optain Health35 shared keywordsHealthcare technology company using robotic retinal imaging, AI and teleophthalmology to screen for eye and systemic disease.
Nikon33 shared keywordsNikon is a manufacturer of imaging products including cameras, lenses, and optical equipment for professional and consumer markets.
Optos28 shared keywordsOptos develops ultra-widefield retinal imaging devices for eyecare professionals to detect, diagnose, document, and treat ocular pathology. The company's devices capture over 80% of the retina in a single image, serving ophthalmologists, optometrists, and other eye care practitioners.
Zeiss27 shared keywordsZEISS Semiconductor Manufacturing Technology provides optics and manufacturing solutions for microchip production, including lithography optics and photomask systems for semiconductor manufacturers worldwide. The company's technologies enable the production of smaller, more efficient, and cost-effective microchips used across electronics, communications, and energy sectors.
Companies competing with Eyenuk for the same Google search keywords, organic and paid, via search-intersection analysis.
Non-dilutive funding · 15 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2020 | $2M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2020 | $300K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2019 | $224.1K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2019 | $218.6K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2018 | $1.5M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2018 | $216.4K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2016 | $2M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2016 | $1.5M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2016 | $1M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2015 | $225K |
| National Institutes of Health (NIH)National Institutes of Health | Phase IISTTR | 2014 | $1.5M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2014 | $788.7K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2014 | $217K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2012 | $399.4K |
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2012 | $260.9K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Eyenuk has filed a notice of an exempt offering of securities to raise $5,648,246.00 in New Funding. - intelligence360intelligence360.news · Jul 2026Frequently asked questions
- What does Eyenuk do?
- Eyenuk provides autonomous AI-based eye exams performed at the point of care to detect eye conditions including diabetic retinopathy (DR), age-related macular degeneration (AMD), and glaucomatous signs. Its technology holds regulatory clearances such as a Class IIb CE mark under EU MDR and maintains SOC 2 Type 2, HIPAA, and GDPR compliance.
- Who founded Eyenuk?
- Eyenuk was founded by Kaushal Solanki in 2013.
- Who are Eyenuk's investors?
- Eyenuk's investors include Kendall Capital Partners.
- How much funding has Eyenuk raised?
- Eyenuk has disclosed $33.9M raised across 5 rounds.
- Where is Eyenuk headquartered?
- Eyenuk is headquartered in Woodland Hills, US.